Intravascular large B-cell lymphoma presenting pulmonary arterial hypertension as an initial manifestation

Internal Medicine

Volumn 49, Issue 1, 2010, Pages 51-54

  Kotake, Takeshi ^a   Kosugi, Satoru ^a   Takimoto, Takayuki ^a   Nakata, Soichi ^a   Shiga, Junko ^a   Nagate, Yasuhiro ^a   Nakagawa, Tsutomu ^a   Take, Hironori ^a   Katagiri, Shuichi ^a  

^a TOYONAKA MUNICIPAL HOSPITAL   (Japan)

Author keywords

18F fluorodeoxyglucose positron emission tomography (FDG PET); Intravascular large B cell lymphoma (IVLBCL); Pulmonary arterial hypertension (PAH)

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; RITUXIMAB; VINCRISTINE; WARFARIN;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; EARLY DIAGNOSIS; HUMAN; INTRAVASCULAR LARGE B CELL LYMPHOMA; LUNG; MALE; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; TRANSBRONCHIAL BIOPSY;

ADULT; HUMANS; HYPERTENSION, PULMONARY; LUNG NEOPLASMS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; POSITRON-EMISSION TOMOGRAPHY; SPLENIC NEOPLASMS;

EID: 74549210120     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2774     Document Type: Article

References (27)

1. Sheibani K, Battifora H, Winberg CD, et al. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. N Engl J Med 314: 943-948, 1986.
2. Zuckerman D, Seliem R, Hochberg E. Intravascular lymphoma: the oncologist's "Great Imitator". The Oncologist 11: 496-502, 2006.
3. Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K. Reassessment of malignant "angioendotheliomatosis". Evidence in favor of its reclassification as "intravascular lymphomatosis". Am J Surg Pathol 10: 112-123, 1986.
4. Snyder LS, Harmon KR, Estensen RD. Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest 96: 1199-1200, 1989.
5. Owa M, Koyama J, Asakawa K, Hikita H, Kubo K, Ikeda S. Intravascular lymphomatosis presenting as reversible severe pulmonary hypertension. Int J Cardiol 75: 283-284, 2000.
6. Aouba A, Diop S, Saadoun D, et al. Severe pulmonary arterial hypertension as initial manifestation of intravascular lymphoma. Am J Hematol 79: 46-49, 2005.
7. Lui PC, Wong GK, Poon WS, Tse GW. Intravascular lymphomatosis. J Clin Pathol 56: 468-470, 2003.
8. Digiuseppe J, Nelson W, Seifter E, Boitnott J, Mann R. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 12: 2573-2579, 1994.
9. Ferreri A, Campo E, Seymour J, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 127: 173-183, 2004.
10. Yousem SA, Colby TV. Intravascular lymphomatosis presenting in the lung. Cancer 65: 349-353, 1990.
11. Demirer T, Dail D, Aboulafia D. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 73: 1738-1745, 1994.
12. Martusewicz-Boros M, Wiatr E, Radzikowska E, Roszkowski-Sliz K, Langfort R. Pulmonary intravascular large B-cell lymphoma as a case of severe hypoxemia. J Clin Oncol 25: 2137-2139, 2007.
13. Sakashita N, Yokose C, Fujii K, Matsumoto M, Ohnishi K, Takeya M. Pulmonary tumor thrombotic microangiopathy resulting from metastatic signet ring cell carcinoma of the stomach. Pathol Int 57: 383-387, 2007.
14. Tan TB, Spaander PJ, Blaisse M, Gerritzen FM. Angiotropic large cell lymphoma presenting as interstitial lung disease. Thorax 43: 578-579, 1988.
15. Jang HJ, Lee KS, Han J. Intravascular lymphomatosis of the lung: Radiologic findings. J Comput Assist Tomogr 22: 427-429, 1998.
16. Nambu A, Kurihara Y, Ichikawa T, et al. Lung involvement in angiotropic lymphoma: CT findings. AJR Am J Roentgenol 170: 940-942, 1998.
17. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25: 571-578, 2007.
18. 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large Bcell lymphoma. Br J Haematol 136: 684, 2007.
19. Lannoo L, Smets S, Steenkiste E, et al. Intravascular large B-cell lymphoma of the uterus presenting as fever of unknown origin (FUO) and revealed by FDG-PET. Acta Clin Belg 62: 187-190, 2007.
20. Hoshino A, Kawada E, Ukita T, et al. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin. Am J Hematol 76: 236-239, 2004.
21. Hofman MS, Fields P, Yung L, Mikhaeel NG, Ireland R, Nunan T. Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT. Br J Haematol 137: 386, 2007.
22. Yago K, Yanagita S, Aono M, Matsuo K, Shimada H. Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction. Rinsho Ketsueki 50: 499-502, 2009.
23. 67galium scintigraphy abnormality. Hematol Oncol 27: 46-49, 2009.
24. Baumann TP, Hurwitz N, Karamitopolou-Diamantis E, Probst A, Herrmann R, Steck AJ. Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol 57: 374-377, 2000.
25. 18Ffluorodeoxyglucose positron emission tomography. Int J Hematol 88: 149-153, 2008.
26. 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 47: 426-431, 2006.
27. 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging 36: 1121-1130, 2009.